<DOC>
	<DOCNO>NCT00429507</DOCNO>
	<brief_summary>Primary objective : - To determine time progression subject breast cancer metastatic bone treat 153Sm-EDTMP Autologous Peripheral Blood Stem Cell Transplantation ( PBSCT ) . Secondary objective : - To determine overall survival one year . - To determine efficacy 153Sm-EDTMP 6 month . - To assess pain subject treat 153Sm-EDTMP . - To determine safety 153Sm-EDTMP .</brief_summary>
	<brief_title>Sm-EDTMP Autologous Peripheral Blood Stem Cell Transplantation Breast Cancer Patients With Bone Only Metastases</brief_title>
	<detailed_description>153 Sm-EDTMP design provide radiation bone bone marrow . The radiation may kill cancer cell . Before start treatment study , `` screening test . '' These test help doctor decide eligible take part study . Your complete medical history record . You physical exam . Blood ( 2 teaspoon ) urine collect routine test . You breast exam , mammogram , compute tomography ( CT ) scan . You bone marrow aspirate/biopsy . To collect bone marrow aspirate/biopsy , area hip chest bone numb anesthetic , small amount bone marrow/bone withdrawn large needle . Blood ( 2 teaspoon ) draw check status disease . You x-rays , bone scan , positron emission tomography ( PET ) scan , bone density test . Blood ( 2 teaspoon ) draw check HIV ( virus cause AIDS ) , CMV ( cytomegalovirus ) , Hepatitis B , Hepatitis C ( virus infect liver ) . You electrocardiogram ( ECG -- test measure electrical activity heart ) . You echocardiogram multiple-gated acquisition scan ( MUGA ) . An echocardiogram us sound wave make picture heart , help show well heart pump blood . You ask lie left side technician place probe gel chest create image heart determine function size . You lung function test make sure heart lungs healthy . You complete questionnaire pain experience . The questionnaire take 15 minute complete . Women able child must negative blood ( 2 teaspoon ) pregnancy test . If find eligible take part study , Day 1 receive tracer dose . A tracer dose small amount study drug use measure study drug affect body . Your weight measure . Before tracer dose inject , give fluid needle vein start 2 hour tracer dose 6 hour afterwards . You receive small amount 153 Sm-EDTMP , call tracer dose , needle vein . After tracer dose , picture take body gamma camera 3 time day . These photograph take immediately dose inject , 2-3 hour 4-6 hour later . You need lie flat image session 10-30 minute time . On Day 2 , 1 picture take body gamma camera . If , base photograph take , doctor find drug go bone expect , remove study . If leave study point , return clinic 2 time week next 4 week . At visit complete physical exam , ask side effect may experience . If enough study drug go bone , receive high dose 153 Sm-EDTMP , call therapy dose , 7-14 day tracer dose . Before therapy dose begin , physical exam , include measurement vital sign . Fluids give needle vein begin 2 hour therapy dose continue 6 hour . You receive injection 153 Sm-EDTMP central line . The injection take 15 minute . Afterwards , vital sign measure . Blood ( 2 teaspoon ) draw routine test . The therapy dose 153 Sm-EDTMP expect destroy body 's ability make blood cell . To restore blood-making ability , give back stem cell ( blood-forming cell ) already take body stored treatment . This call autologous peripheral blood stem cell transplant . You receive stem cell give needle vein 14-21 day therapy dose usually outpatient procedure . Family member may allow radiation subsides . This reduce exposure radiation . You give instruction follow radiation safety practice . Once radiation subsides release hospital , least 2 time week complete physical exam , ask side effect experience . Blood ( 2 teaspoon ) draw 3 time week stem cell transplant . Your vitals sign also check 2 time week . After transplant , least 2 time week two ( 2 ) week blood ( 2 teaspoon ) draw routine test . You physical exam vital sign check . You receive additional care , drug , blood transfusion , need . You return follow-up visit every 3 month end Year 2 every 6 month Years 3 4 . Tests may occur often side effect notice . Any side effect develop monitor go away . Some exams test may take place home doctor , record need send study doctor he/she review careful monitoring . In order check response cancer study therapy , chest x-ray , CT scan , bone scan every 3 month first 2 year transplant . These repeat every 6 month year 3-4 year , long cancer get bad . If breast cancer spread bone marrow time enter study , bone marrow biopsy also do time see whether cancer respond . You also PET scan 6 month transplant , often physician believe helpful . Mammograms bone density exams do year . Once year 10 year leave study , study visit contact telephone . You ask general health , hospitalization , cancer treatment . This investigational study . 153 Sm-EDTMP FDA-approved commercially available bone pain control . Up 40 patient take part study . All enrol M. D. Anderson .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Samarium ethylenediaminetetramethylenephosphonate</mesh_term>
	<criteria>1 . Stage IV breast cancer metastatic bone and/or bone marrow . 2 . Age 18 65 year . 3 . Eastern Cooperative Oncology Group ( ECOG ) performance score 0 , 1 4 . Subjects breast tumor hormone receptor positive disease ( ER+/PR+ , ER+/PR , ER/PR+ ) must fail least one hormonalbased therapy bone disease . 5 . Subjects breast tumor hormone receptor negative disease must fail least one anthracycline and/or taxanebased therapy bone disease . 6 . White blood cell count ( WBC ) &gt; /= 3.5 x10^9/L , Hb &gt; /= 10 g/dL , platelet &gt; /= 100 x10^9/L . 7 . Adequate pulmonary function define forced expiratory volume one second ( FEV1 ) , force vital capacity ( FVC ) diffuse capacity lung carbon monoxide ( DLCO ) ( correct hemoglobin ) &gt; /= 50 % predict . 8 . Adequate cardiac function evidence leave ventricular ejection fraction ( LVEF ) &gt; /= 45 % . 9 . Serum total bilirubin &lt; 2x upper limit normal ( ULN ) , ALT/serum glutamate pyruvate transaminase ( SGPT ) &lt; 3x ULN 10 . Creatinine clearance &gt; /= 75 mL/min subject 50 year age , adjust age 10 % decrease per decade subject 50 year age . 11 . Ability understand study provide inform consent . 1 . Any metastatic disease history metastatic disease skeletal metastases 2 . Impending fracture , spinal cord compression , and/or potentially unstable compression fracture vertebral body possibility cord compression . 3 . Previous strontium89 samarium153 treatment skeletal involvement . 4 . Cumulative external beam radiation &gt; 20 % marrow volume &gt; 40 Gy single region spinal cord . 5 . Prior radiation bladder kidney , define radiation portal directly include volume either kidney and/or bladder . 6 . Life expectancy severely limited concomitant illness ( le 6 month ) . 7 . Prior nephrectomy . 8 . History hemorrhagic cystitis obstructive uropathy hydronephrosis . 9 . Uncontrolled arrhythmia symptomatic cardiac disease . 10 . Current gross hematuria urinalysis ( UA ) absence vaginal bleeding . 11 . Evidence HIVseropositivity . 12 . Inability stop chemotherapy treatment breast cancer within 3 week precede high dose Samarium . 13 . Use investigational agent within 30 day precede enrollment . 14 . Pregnant lactating woman . 15 . Other current prior malignancy except adequately treat basal cell squamous cell skin cancer situ cervical cancer . 16 . Myelodysplastic syndrome . 17 . Subject weight 125 kg .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Blood Stem Cell</keyword>
	<keyword>Bone Metastases</keyword>
	<keyword>Radiation Therapy</keyword>
	<keyword>Gamma Camera</keyword>
	<keyword>Sm-EDTMP</keyword>
	<keyword>Samarium 153-EDTMP</keyword>
	<keyword>Stem Cell Transplant</keyword>
	<keyword>Autologous Peripheral Blood Stem Cell Transplantation</keyword>
	<keyword>PBSCT</keyword>
	<keyword>Questionnaire</keyword>
</DOC>